Skip to Main Content

Paper Details

Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40.
Nature Communications
57
2021
CD40, CTLA-4, GBM, GBM-associated Ms, GL261, GL261 tumors, HIF-1, IL-6, Immunologically-cold tumors, Ms, PD-1, Stat3, T-cell, glioblastoma, immunosuppressive macrophages, mouse, tumor, tumors
  • 1 - 1

Datasets